XORTX Therapeutics (XRTX) Stock Price, News & Analysis

Company Overview

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

Key Stats

• Today's Range: $0.85 to $0.87
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 15,673 shs
• Average Volume: 21,370 shs
• Market Capitalization: $3.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XRTX Stock Analysis - Frequently Asked Questions

How were XORTX Therapeutics' earnings last quarter?

XORTX Therapeutics Inc. (NASDAQ:XRTX) posted its quarterly earnings data on Thursday, May, 15th. The technology company reported ($0.19) earnings per share (EPS) for the quarter.

When did XORTX Therapeutics' stock split?

XORTX Therapeutics shares reverse split on Friday, November 10th 2023. The 1-9 reverse split was announced on Friday, November 10th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 10th 2023. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split.

What other stocks do shareholders of XORTX Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that XORTX Therapeutics investors own include NVIDIA (NVDA), Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN) and EUDA Health (EUDA).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 6/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: NASDAQ:XRTX
• CIK: 1284823
• Web: www.xyratex.com
• Phone: +44-23-92496000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.35)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.31 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -36.38%
• Return on Assets: -24.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.78
• Quick Ratio: 2.78

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.88 per share
• Price / Book: 0.99

Miscellaneous

• Outstanding Shares: 3,790,000
• Free Float: 3,527,000
• Market Cap: $3.31 million
• Optionable: Not Optionable
• Beta: 0.52